PRESS ROOM

ADAP Advocacy issued the following press releases:

ADAP Advocacy Rescinds Three-Year Florida Travel Advisory

Ongoing Threats to Accessing Care and Treatment Facing Floridians Living with HIV/AIDS Warrants New Advocacy Strategy

WASHINGTON, D.C. - ADAP Advocacy today announced it has rescinded its travel advisory for people living with HIV/AIDS, which was issued in May 2023. The three-year-old travel advisory had applied to ADAP Advocacy board members, staff, consultants, and scholarship-funded patient advocates, and had also suspended hosting any patient advocacy events in Florida.

Download the Press Release: Google Docs Viewer PDF

ADAP Advocacy is an Organizational Partner of SYNC 2026

National Conference to be held March 18th-20th in Arlington, VA

WASHINGTON, D.C. - ADAP Advocacy today announced it is a proud organizational partner of the SYNChronicity 2026 (#SYNC2026) Annual National Conference for HIV, HCV, STIs, Drug User Health, and LGBTQ Health, to be held March 18th-20th in Arlington, Virginia.

Download the Press Release: Google Docs Viewer PDF

ADAP Advocacy Urges Congress to Reject 340B Special Carveouts

Improving Patient Access and Affordability Depends on the Universal Implementation of the 340B Drug Pricing Program Rebate Model

WASHINGTON, D.C. - ADAP Advocacy cautions against "special" carveouts for Federally Qualified Health Centers (FQHCs), or any other covered entities, participating in the federal 340B Drug Pricing Program. The Trump Administration has joined a growing chorus calling for long-overdue reforms to the 340B Program, most notably by proposing a rebate model to replace the current upfront payments that drug manufacturers make to covered entities, which have led to increasing waste, fraud, and abuse.

Download the Press Release: Google Docs Viewer PDF

ADAP Advocacy Urges Congress to Rein in Greedy American Health Insurance Companies

Major health insurers continue to rake in profits at the expense of patients, reporting revenue growth of 7.8% or greater, while patients struggle to afford ACA marketplace premium increases averaging 21.7% of Silver-level plans

WASHINGTON, D.C. - ADAP Advocacy insists that patients’ health is significantly more important than corporate profits for American health insurance companies. This message, however, seems not to have reached the ears of the four major health insurance companies, whose CEOs today testified before Congress before the House Committee on Energy and Commerce and the House Committee on Ways and Means.

Download the Press Release: Google Docs Viewer PDF

Past Press Releases:
[2025] · [2024] · [2023] · [2022] · [2021] · [2020] · [2019] · [2018] · [2017] · [2016] · [2015] · [2014] · [2013] · [2012] · [2011] · [2010] · [2009]